Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in
J
apanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study
2015 ◽
Vol 17
(8)
◽
pp. 800-804
◽
2014 ◽
Vol 126
(7-8)
◽
pp. 228-237
◽
2012 ◽
Vol 34
(9)
◽
pp. 1909-1919.e15
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 122
◽
pp. 78-83
◽
2019 ◽
Vol 38
(8)
◽
pp. 714-721
◽